Risk factors associated with cardiovascular morbidity and mortality in spanish incident hemodialysis patients: Two-year results from the ANSWER study

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 21-29

  Cuevas, Xavier ^a   García, Fernando ^b   Martín Malo, Alejandro ^c   Fort, Joan ^d   Lladós, Fina ^e   Lozano, Javier ^e   Pérez García, Rafael ^f  

^a Brain   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e Amgen SA   (Spain)

^f HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

Albumin; Body mass index; Cardiovascular disease; Catheter; Ferritin; Hemodialysis

Indexed keywords

ALBUMIN; ANTIANEMIC AGENT; FERRITIN;

ANALBUMINEMIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHARLSON SCORE; COHORT ANALYSIS; COMORBIDITY; FEMALE; FERRITIN DEFICIENCY; HEART ARRHYTHMIA; HEART FAILURE; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; IRON DEFICIENCY; ISCHEMIC HEART DISEASE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MESENTERIC BLOOD VESSEL OCCLUSION; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEFICIENCY; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SPAIN; VASCULAR ACCESS;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CATHETERS; FEMALE; FERRITINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; SPAIN;

EID: 82355164330     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000332395     Document Type: Article

References (56)

1. Linder A, Charra B, Sherrard DJ, et al: Accelerated atherosclerosis in prolonged maintenance hemodyalisis. N Engl J Med 1974; 290:697-701.
2. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
3. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277.
4. Jungers P, Khoa TN, Massy ZA, et al: Incidence of atherosclerotic, arterial occlusive accidents in predialysis and dialysis patients. A multicentric study in the Ile de France district. Nephrol Dia l Transplant 1999; 14: 898-902.
5. Portoles J, Gorriz JL, Martinez-Castelao A, et al: One-year mortality and risk factors management in diabet ic versus non-diabetic patients with chronic kidney disease stages 3 and 4. Merena study. Nephrol Dial Transplant 2007; 21:393.
6. Keith DS, Nichols GA, Gullion CM, et al: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164:659-663.
7. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(suppl 12):16-23.
8. Brown JH, Hunt LP, Vites NP, et al: Comparative mortality from cardiovacular disease in patient with chronic renal failure. Nephrol Dial Transplant 1994; 9: 113 6-1142.
9. Raine AEG, Margreiter R, Brunner FP, et al: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992;(suppl 7):7-35.
10. Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192.
11. Zoccali C: Cardiovascular risk in uremic patients, is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15: 454-457.
12. Longenecker JC, Coresh J, Powe NR, et al: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002; 13: 1918-1927.
13. López Gómez JM, Jofré R, Cases A: Factores de riesgo cardiovascular en la enfermedad renal crónica. Nefrologia 2002; 22(suppl 1):59-67.
14. Koch M, Kutkuhn B, Trekwalder E, et al: Apolipoprotein B, fibrinogen, HDL colester-ol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997; 8:1889-1898.
15. Zimmermann J, Herrlinger S, Pruy A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658.
16. Wratten ML, Galaris D, Tetta C, et al: Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Antioxid Redox Signa l 2003; 4: 935-944.
17. Ronco C, Bowry S, Tetta C: Dialysis patients and cardiovascular problems: can technology help solve the complex equation? Blood Purif 2006; 24: 39-45.
18. Goodkin DA, Mapes DL, Held PJ: The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients. Semin Dial 2001; 14: 157-159.
19. Goodkin DA, Young EW: An update on the dialysis outcomes and practice patterns study (DOPPS). Contemp Dial Nephrol 2001; 22:36-40.
20. Trespalacios FC, Taylor AJ, et al: Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 2002; 62: 179 9-180 5.
21. Trivedi H, Xiang Q, Klein JP: Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transpla nt 2009; 24: 258-266.
22. Tanaka Y, Joki N, Hase H: History of acute coronary events during the predialysis phase of chronic kidney disease is a strong risk factor for major adverse cardiac events in patients initiating hemodialysis. Nephrol Dial Transplant 2007; 22:2917-2923.
23. Pernod G, Bosson JL, Golshayan D, et al: Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort. Kidney Int 2006; 69:1424-1430.
24. Pérez-García R, Martín-Malo A, Fort J, et al: Baseline characteristics of an incident hae-modialysis population in Spain: results from ANSWER-a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 2009; 24:578-588.
25. Boyle P, Parkin DM: Statistical methods for registries; in Jensen OM, Parkin DM, Mac Lennan R, Muir CS, Skeet RG (eds): Cancer Registration, Principles and Methods. Lyon, IARC, 1991, pp 126-158.
26. de Jager DJ, Grootendorst DC, Jager KJ, et al: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789.
27. Bradbury BD, Fissell RB, Albert JM, et al: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007; 2:89-99.
28. Schwaiger JP, Neyer U, Sprenger-Mähr H, et al: A simple score predicts future cardiovascular events in an inception cohort of dialysis patients. K idney Int 2006; 70: 543-548.
29. Wanner C, Zimmermann J, Schwedler S, et al: Inflammation and cardiovascular risk in dia lysis patients. Kidney Int Suppl 2002; 99-102.
30. Kessler M, Zannad F, Lehert P, et al: Predictors of cardiova scular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study. Nephrol Dial Transpla nt 2007; 22: 3573-3579.
31. Volkova N, Arab L: Evidence-based systematic literature review of hemoglobin/hema-tocrit and all-cause mortality in dialysis patients. Am J Kidney Dis 2006; 47: 24-36.
32. Regidor DL, Kopple JD, Kovesdy CP, et al: Associations between changes in hemoglobin and administered erythropoiesis-stimu-lating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006; 17:1181-1191.
33. Locatelli F, Pisoni RL, Akizawa T, et al: Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) f indings. Am J Kidney Dis 2004; 44: 27-33.
34. Szczech LA, Barnhart HX, Inrig JK, et al: Secondary analysis of the CHOIR trial epo-etin-alpha dose and achieved hemoglobin outcomes. Kidney Int 2008; 74: 791-798.
35. Kalantar-Zadeh K, McAllister CJ, Lehn RS, et al: A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis 2004; 43:671-684.
36. Kalantar-Zadeh K, Regidor DL, McAllister CJ, et al: Time-dependent associations between iron and mortality in hemodialysis patients. J A m Soc Nephrol 2005; 16: 3070-3080.
37. Fishbane S, Kalantar-Zadeh K, Nissenson AR: Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment. Semin Dial 2004; 17: 336-341.
38. Kalantar-Zadeh K, Hoffken B, Wunsch H, et al: Diagnosis of iron deficienc yanemiainrenal failure patients during the post-erythro-poietin era. Am J K idney Dis. 1995 26, 292-299.
39. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH: Association between serum fer-ritin and measures of inflammation, nutrition and iron in hemodialysis patients. Nephrol Dial Transplant 2004; 19: 141-149.
40. Drueke T, Witko-Sarsat V, Massy Z, et al: Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002; 106:2212-2217.
41. Feldman HI, Santanna J, Guo W, et al: Iron administration and clinical outcomes in he-modialysis patients. J Am Soc Nephrol 2002; 13: 734-744.
42. Feldman HI, Joffe M, Robinson B, et al: Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 2004; 15:1623-1632.
43. Fort J, Cuevas X, García F, et al: Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoi-esis-stimulating agent dose are independent predictive factors in the ANSWER study. Nephrol Dial Transplant 2010; 25:2702-2710.
44. Undas A, Kolarz M, Kopec G, et al: Altered fibrin clot properties in patients on long-term haemodialysis: relat ion to cardiovas c u-lar mortality. Nephrol Dial Transplant 2008; 23: 2010-2015.
45. Wiesholzer M, Harm F, Tomasec G, et al: Incidence of stroke among chronic hemodialy-sis patients with nonrheumatic atrial fibrillation. A m J Nephrol 2001; 21: 35-39.
46. Abbott KC, Trespalacios FC, Taylor AJ, et al: Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospital-ization and mortality. BMC Nephrol 2003; 4: 1-10.
47. Canabal A, Sabate J, Salgueira M, et al: Ma-mografia y riesgo cardionefrovascular. Estu-dio de las calcificaciones vasculares en la in-suficiencia renal cronica. Radiologia 2008; 50:54-60.
48. Blacher J, Pannier B, Guerin AP, et al: Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570-574.
49. Agarwal R: Hypertension and survival in chronic hemodialysis patients-past lessons and future opportunities. Kidney Int 2005; 67:1-13.
50. Leavey SF, McCullough K, Hecking E, et al: Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394.
51. Fleischmann E, Teal N, Dudley J, et al: Influence of excess weight on mortality and hospital stay in 1,346 hemodialysis patients. Kidney Int 1999; 55:1560-1567.
52. Port FK, Ashby VB, Dhingra RK, et al: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066.
53. Lopes AA, Bragg-Gresham JL, Elder SJ, et al: Independent and nutritional status of joint associations with mortality risk indicators among chronic hemodialysis in the Dialysis Patients Outcomes and Practice Patterns Study (DOPPS). J Ren Nutr 2010; 20:224-234.
54. Mutsert R, Grootendorst DC, Indemans F, et al: Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009; 19: 127-135.
55. Gruss E, Portolés J, Caro P, et al: Los modelos de atencion al acceso vascular condicionan resultados heterogeneos en los centros de una misma comunidad. Nefrologia 2010; 30: 310-316.
56. Gruss E, Portolés J, Tato A, et al: Repercusio-nes clínicas y económicas del uso de catéteres tunelizados de hemodiálisis en un area sanitaria. Nefrologia 2009; 29:123-129.